SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.80
Ask:
77.20
Spread: 1.40 (1.847%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Strategic Partnership

28 Mar 2007 07:04

Accsys Technologies PLC28 March 2007 28th March 2007 AIM: AXS Accsys announces strategic partnership and supply agreement with Celanese, Celanese to make investment of €22 million Accsys Technologies PLC ("Accsys" or "the Company") has signed a long termexclusive supply agreement with Celanese Corporation ("Celanese"), the globalleader in acetyls, which has a market capitalization of $5 billion, and is quoted on the New York Stock Exchange (symbol 'CE'). Under the agreement, Accsys (www.accsysplc.com) will be able to ensure supply ofacetyls to the licensees of its proprietary Accoya(TM) wood production process,wherever they are in the world. This will enable Accsys' licensees toconcentrate their investment spending on the core wood modification business andis expected to accelerate the uptake of Accoya(TM) technology around the world. Celanese (www.celanese.com) with net sales of US$6.7 billion (2006), is theleader in the global acetyls market and is committed to maintaining its leadingposition through growth and innovation. This agreement allows Celanese tocapture the growth in acetyls demand that Accsys' proprietary wood acetylationtechnology is expected to generate. In addition, Celanese has taken an option toevaluate and acquire Accsys' proprietary acetic anhydride production technology. Celanese is further demonstrating its commitment to Accsys' business bysubscribing for new shares, subject to shareholder approval, representingapproximately 5.5% of Accsys' issued share capital (post event) at a 5% premiumto the closing share price on 27th March 2007. This equity transaction willinvolve the acquisition of 8,115,883 newly issued shares at a price of €2.72 pershare, representing an investment in the Company of €22M ($29.5M). Celanese willhave an option to increase its ownership of Accsys to 29.9% in the future at themarket price at that time. If approved by Accsys' shareholders at an EGM, thetransaction at €2.72 per share values Accsys at approximately €400 million. Willy Paterson-Brown, Executive Chairman of Accsys, commented: "This is asignificant transaction for Accsys and clearly demonstrates how far the Companyhas come since listing on AIM in October 2005. The strategic partnership withCelanese is the perfect fit, which guarantees supply of acetyls for ourLicensees, as well as our own operations in Arnhem. It also allows our Licenseesto focus their own capital investment on wood capacity, rather than chemicalsupport and, as a result, will have value for all concerned. We are delightedthat Celanese have chosen to take an equity stake in the Company, and welcometheir input on our Board of Directors." Finlay Morrison, Vice President of Acetyl Intermediates at Celanese, added: "Thestrategic partnership with Accsys is clearly a win-win situation. The potentialgrowth of Accsys over the next decade and the value that Celanese can add tothat growth will have a positive impact to both companies' performances. It isclear that Accsys' Accoya(TM) technology creates a tremendous opportunity forcompanies in the wood industry, as well as for architects, constructioncompanies and consumers who are looking for more environmentally sustainablebuilding materials." Following the announcement earlier this month of commercial production ofAccoya(TM) wood at Accsys' 100% subsidiary, Titan Wood's (www.titanwood.com) new30,000 m3 Arnhem facility, the Company's order books are virtually full throughto the end of 2007, with production committed into a wide range of differentproduct applications, from civil construction to joinery. The combination oflarge-scale commercial production now underway with the security of supply ofacetyls being supplied by Celanese is expected to simplify and strengthen thelicence proposition, accelerating the take up of the technology by potentiallicensees. The additional capital in the business will be focused on supportingthe growth of licensing, as well as further development of Accsys' proprietarytechnologies, including wood fibre. Willy Paterson-Brown added: "The completion of the agreement with Celaneseprovides confidence in our technologies and a springboard for future commercialdevelopment. The transaction is a major landmark for Accsys and will allow us toreview our entire chemical supply strategy in a new light. With successfulproduction in Arnhem, and supply of acetyls secure, we are now able to turn ourattention to licensing, which we had placed on hold while we negotiated termswith Celanese. Although this will impact results to March 31st 2007, the firstfull license should be signed in the Second Quarter and the several licenceoptions that are presently under negotiation are expected to mature,accelerating our future growth." All these agreements with Celanese are conditional upon Accsys' shareholders'approval of the equity transaction. A Circular seeking approval, at anExtraordinary General Meeting, will be dispatched to Accsys shareholders at thebeginning of April. ENDS For further information, please contact: Accsys Technologies PLC William Paterson-Brown, +44 (0) 20 8122 9191www.accsysplc.com Executive Chairman Collins Stewart Limited Tim Mickley / Michael O'Brien +44 (0) 20 7523 8000 Parkgreen Communications Justine Howarth / Clare Irvine +44 (0) 20 7851 7480 Notes to Editors About Celanese As a global leader in the chemicals industry, Celanese Corporation (NYSE: CE)makes products essential to everyday living. Our products, found in consumerand industrial applications, are manufactured in North America, Europe and Asia.Net sales totalled $6.7 billion in 2006, with approximately 60% generatedoutside of North America. Known for operational excellence and execution of itsbusiness strategies, Celanese delivers value to customers around the globe withinnovations and best-in-class technologies. Based in Dallas, Texas, the companyemploys approximately 8,900 employees worldwide. For further information aboutCelanese, please visit www.celanese.com. Titan Wood Limited (www.titanwood.com) is wholly owned subsidiary of the AccsysTechnologies PLC (www.accsysplc.com) group of companies. Accsys Technologies PLCis listed on the London Stock Exchange AIM market under the symbol 'AXS'. Wood Acetylation is a process, which increases the amount of 'acetyl' moleculesin wood, thereby changing its physical properties. The process protects woodfrom rot by making it "inedible" to most micro-organisms and insects, without -unlike conventional treatments - making it toxic. It also greatly reduces thewood's tendency to swell and shrink, making it less prone to cracking andensuring that when painted it requires dramatically reduced maintenance. Accoya(TM) wood (www.accoya.info) is produced using a patented process thateffectively converts sustainably grown softwoods and non-durable hardwoods intowhat is best described as a 'new wood species'. Distinguished by its durability,dimensional stability and, perhaps most importantly of all, its reliability (interms of consistency of both supply and quality), Accoya(TM) wood is particularlysuited to exterior applications where performance and appearance are valued.Unlike most tropical and European hardwoods, its colour does not degrade whenexposed to ultraviolet light. Moreover, the Accoya(TM) wood production processdoes not compromise the wood's strength or machinability. The combination of UVresistance, dimensional stability, durability and retained strength means thatAccoya(TM) wood offers a wealth of new opportunities to architects, designers andspecifiers. For marine uses where weight is also important, Accoya(TM) wood forthe first time provides boat builders with a wood that is strong, lightweight,durable and which retains its natural beauty for far longer. ACCOYA is a registered trademark owned by Titan Wood Limited This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
2nd Sep 20245:00 pmRNSTotal Voting Rights
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.